Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04437472 · ClinicalTrials.gov registry record
Remote Collection of Patient Reported Toxicity Using SMS Text Messaging (CareSignal)
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 30
- Enrollment target
NCT04437472 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 30 participants.
The verdict
NCT04437472 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
CareSignal has developed an application that allows for remote collection of patient-reported data such as symptoms or outcomes on any device compatible with the short message service (SMS), otherwise known as "text messaging". The software can be configured to complete symptom monitoring by surveying patients about toxicity using the PRO-CTCAE tools. PRO-CTCAE is the patient reported outcomes version of the CTCAE that was designed by the National Cancer Institute (NCI) for use in clinical trials.
Interventions
- OTHER CareSignal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2020-09-22 |
| Est. Completion | 2021-07-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04437472
The ClinicalTrials.gov registry entry for NCT04437472 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CareSignal is the first listed.
NCT04437472 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04437472 about?
NCT04437472 is a clinical study titled "Remote Collection of Patient Reported Toxicity Using SMS Text Messaging (CareSignal)". CareSignal has developed an application that allows for remote collection of patient-reported data such as symptoms or outcomes on any device compatible with the short message service (SMS), otherwise known as "text messaging". The software can be configured to complete symptom monitoring by surveyi...
What is the current status of trial NCT04437472?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2020-09-22. Estimated completion is 2021-07-09.
What interventions are being tested in trial NCT04437472?
The interventions under investigation include: CareSignal (OTHER).
Who is sponsoring clinical trial NCT04437472?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.